Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria

BACKGROUND: The effects of direct-acting antivirals (DAAs) on survival and recurrence rates after curative hepatocellular carcinoma (HCC) treatment in patients with hepatitis C virus (HCV) infection remain controversial. METHODS: This retrospective, multicenter study involved Child–Pugh class A pati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Gastroenterol
Autors principals: Ochi, Hironori, Hiraoka, Atsushi, Hirooka, Masashi, Koizumi, Yohei, Amano, Michiko, Azemoto, Nobuaki, Watanabe, Takao, Yoshida, Osamu, Tokumoto, Yoshio, Mashiba, Toshie, Yokota, Tomoyuki, Abe, Masanori, Michitaka, Kojiro, Hiasa, Yoichi, Joko, Kouji
Format: Artigo
Idioma:Inglês
Publicat: Springer Singapore 2020
Matèries:
Original Article—Liver, Pancreas, and Biliary Tract
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7819935/
https://ncbi.nlm.nih.gov/pubmed/33278003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-020-01747-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars